ISPE Highlights
Pharmaceutical Engineering Magazine
Highlights From ISPE Knowledge Network
- Strategic Planning for Measurable Outcomes in Pharmaceutical Manufacturing
- Honoring Sustainability and Innovation: United Therapeutics’ FOYA Honorable Mention
- Zydus Pharmaceuticals Recognized as FOYA 2024 Honorable Mention Award Winner
- Good Practice Guide: SMEPAC - Standardized Methodology for the Evaluation of Pharma Airborne Particle Emissions from Containment Systems 3rd Edition
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Unlock the Future of Pharmaceutical Manufacturing: Learn from Industry Leaders at the 2024 ISPE Pharma 4.0™ and Annex 1 Conference
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Overcoming Fear of the Engineer-Procure-Construct (EPC) Model to Recognize Project Execution Benefits
- EMA Executive Director Discusses the Future of Innovation and Regulation
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Explore the Possibilities of Pharmaceutical Advancement with Digital Tools, Including AI/ML at the 2024 ISPE Annual Meeting & Expo
- Strategic Planning for Measurable Outcomes in Pharmaceutical Manufacturing
- Honoring Sustainability and Innovation: United Therapeutics’ FOYA Honorable Mention
- Zydus Pharmaceuticals Recognized as FOYA 2024 Honorable Mention Award Winner
- Good Practice Guide: SMEPAC - Standardized Methodology for the Evaluation of Pharma Airborne Particle Emissions from Containment Systems 3rd Edition
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Unlock the Future of Pharmaceutical Manufacturing: Learn from Industry Leaders at the 2024 ISPE Pharma 4.0™ and Annex 1 Conference
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Overcoming Fear of the Engineer-Procure-Construct (EPC) Model to Recognize Project Execution Benefits
- ICH Q7: API Guidelines
- Advancing Precision Medicine with ADCs and Radiopharmaceuticals
- Process Considerations When Designing mAbs Production Facilities
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- ICH Q7: API Guidelines
- ICH Q8: QbD in Manufacturing
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- EMA Executive Director Discusses the Future of Innovation and Regulation
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Explore the Possibilities of Pharmaceutical Advancement with Digital Tools, Including AI/ML at the 2024 ISPE Annual Meeting & Expo
Explore the benefits of ISPE membership.